
DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER
Author(s) -
I. S. Yavelov
Publication year - 2011
Publication title -
racionalʹnaâ farmakoterapiâ v kardiologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.161
H-Index - 9
eISSN - 2225-3653
pISSN - 1819-6446
DOI - 10.20996/1819-6446-2011-7-6-757-764
Subject(s) - dabigatran , medicine , atrial fibrillation , safer , dosing , intensive care medicine , clinical trial , randomized controlled trial , warfarin , cardiology , computer security , computer science